论文部分内容阅读
目的评价丹红注射液联合三磷酸胞苷二钠注射液治疗急性脑梗死(ACI)的临床疗效。方法将80例急性脑梗死患者随机分成治疗组和对照组。治疗组采用丹红注射液20ml,三磷酸胞苷二钠注射液40mg,每日一次静脉滴注,10d为1疗程,对照组采用血栓通注射液20ml及胞二磷胆碱注射液0.75g,每日一次静脉滴注,10d为1疗程的治疗方案。评价治疗前和治疗后的神经功能缺损评分。结果治疗组与对照组比较,神经功能缺损评分改善显著(P<0.01),治疗组显效率高于对照组(P<0.05)。结论丹红注射液联合三磷酸胞苷二钠注射治疗急性脑梗死比常规治疗效果好,并且安全、可靠。
Objective To evaluate the clinical efficacy of Danhong injection combined with cytidine disodium triphosphate injection in the treatment of acute cerebral infarction (ACI). Methods Eighty patients with acute cerebral infarction were randomly divided into treatment group and control group. The treatment group with Danhong injection 20ml, cytidine disodium phosphate injection 40mg, once daily intravenous infusion, 10d for a course of treatment, the control group with thrombosis injection 20ml and citicoline 0.75g, Once daily intravenous infusion, 10d for a course of treatment options. Neurological deficit scores were evaluated before and after treatment. Results Compared with the control group, the neurological deficit score improved significantly (P <0.01), and the effective rate of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion Danhong injection combined with cytidine disodium injection in the treatment of acute cerebral infarction is more effective than conventional treatment and safe and reliable.